Hasil Pencarian - Daphne Day

  • Menampilkan 1 - 14 hasil dari 14
Perbaiki Hasil
  1. 1
    Approaches to modernize the combination drug development paradigm

    Approaches to modernize the combination drug development paradigm oleh Daphne Day, Lillian L. Siu

    Diterbitkan 2016-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Synchronous p16+ nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and review

    Synchronous p16+ nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and review oleh Muhammad Ali, Hock Kua, Charles Giddings, Daphne Day, Lachlan McDowell

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution

    Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution oleh Siddharth Menon, Amy Davies, Sophia Frentzas, Cheryl‐Ann Hawkins, Eva Segelov, Daphne Day, Ben Markman

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit

    Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit oleh Genevieve Dall, Karen Harris, Nonie Chan, Stephen J. Luen, Sophia Frentzas, Daphne Day, Michelle Barrett, Anna Kilgour, Mark Buzza

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial

    Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial oleh Daphne Day, Han Chong Toh, Raghib Ali, Estelle Mei Jye Foo, John Simes, John Whay Kuang Chia, Eva Segelov

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature

    Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature oleh Steven David, Gwo Ho, Daphne Day, Marion Harris, Jennifer Tan, Shom Goel, Gerard G. Hanna, Ranjana Srivastava, Gill Kruss, Lachlan McDowell, Michelle White

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia

    COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia oleh Holly Wang, Lisa Grech, Jennifer Wong, David Hoffman, Barbora de Courten, Brett Sillars, Mark Savage, Alastair Kwok, Mike Nguyen, Nathan Bain, Daphne Day, Eva Segelov, on behalf of the DIABVACCS Investigators

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model

    Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Usin... oleh Tammie Choi, Bryan Chan, Lisa Grech, Alastair Kwok, Kate Webber, Jennifer Wong, Mike Nguyen, Nathan Bain, Daphne Day, Amelia McCartney, Ruby Hamer, Eva Segelov, on behalf of the CANVACCS DIABVACCS and MSVACCS Investigators

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial

    Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial oleh Alberto Hernando‐Calvo, Eoghan Malone, Daphne Day, Amy Prawira, Ilan Weinreb, S. Y. Cindy Yang, Horace Wong, Angela Rodriguez, Sarah Jennings, Anneli Eliason, Lisa Wang, Anna Spreafico, Lillian L. Siu, Aaron R. Hansen

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial

    Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial oleh Eva Segelov, Hans Prenen, Daphne Day, C. Raina Macintyre, Estelle Mei Jye Foo, Raghib Ali, Quanyi Wang, Xiaoting Wei, Gilberto de Lima Lopes, Kefeng Ding, Gong Chen, John Whay Kuang Chia, Han Chong Toh

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers

    COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers oleh Nathan Bain, Mike Nguyen, Lisa Grech, Daphne Day, Amelia McCartney, Kate Webber, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Louise Nott, Nada Hamad, Annette Tognela, Craig Underhill, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS Investigators

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

    SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer oleh Hui Li, Mark Voskoboynik, Qing Zhou, Hongming Pan, Juan Zhang, Yi-Long Wu, Bo Gao, Jun Zhao, Yunpeng Liu, Qian Chu, Lifeng Wang, Jiuwei Cui, Daphne Day, Xinmin Yu, Dingzhi Huang, Zhiyong Ma, Meili Sun, Jingxun Wu, Zhehai Wang, Yanyan Peng

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

    Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia oleh Daphne Day, Lisa Grech, Mike Nguyen, Nathan Bain, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Richard Blennerhassett, Louise Nott, Nada Hamad, Annette Tognela, David Hoffman, Amelia McCartney, Kate Webber, Jennifer Wong, Craig Underhill, Brett Sillars, Antony Winkel, Mark Savage, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors

    Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat... oleh Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: